Introduction
It is becoming increasingly apparent that growth is not solely hormone driven but is also regulated by receptors and post-receptor processes in target tissues (Daughaday, 1989; Spencer, 1985) . In ruminants, poor nutrition is associated with elevated concentrations of growth hormone (GH) in plasma and with reduced numbers of the high-affiiity GH receptor in liver Breier et al., 1988) . In contrast, plasma concentrations of the insulin-like growth factors (IGF1 and IGF-2) in sheep are depressed by periods of restricted nutrition or fasting (Hodgkinson et al., 1987; Bass et al., 1984) .
Few studies have investigated whether the IGF Type 1 and Type 2 receptors are also sensitive to changes in nutrition. Lowe et al. (1989) demonstrated an increase in IGF-1 binding and type 1 receptor mRNA in several tissues from fasted rats. These authors considered that this may have resulted from the removal of downregulating influences of normal plasma IGFs. Food restriction in rats also increases the number of unoccupied type 1 receptors in the median eminence of the brain (Bohannon et al., 1988) . The binding of insulin to muscle membranes is increased in poorly fed sheep (Grizard, 1983) , and the present investigation was under-taken to determine whether the IGF receptors in ovine skeletal muscle were also controlled by nutrition.
As a consequence of the structural homologies of the IGFs, insulin, and their receptors, the hormones are capable of cross-binding with reduced affinity to heterologous receptors (Underwood and Van Wyk, 1985) . Insulin competes for [12'I]-IGF binding to the Type 1 receptor, but not the Type 2 receptor , so the significance of competition for binding by insulin at relatively low and high concentrations with respect to the tracer can be used to determine whether binding of IGFs is to Type 1, Type 2, or insulin receptors. This principle has previously been employed in studies of IGF tracer binding using membrane receptor preparations (Duclos and Goddard, 1990; Alexandrides et al., 1989) .
Autoradiography and related histochemical techniques have the advantage over biochemical assay of anatomic localization of compounds in situ (Palacios and Dietl, 1987; Clark and Hall, 1986) . Dub6 et al. (1980) compared data obtained by autoradiography and radioreceptor assay and reported good agreement between relative grain densities in autoradiographs and data from the assay. To date, light microscopic autoradiography has not been used as a quantitative method for IGF receptor measurement in different cell types within a tissue. We have used this technique in such a manner to locate, characterize, and quantify the binding sites for ['*>I]-IGFl and [ 1z51]-IGF-2 in situ, to different cell types in skeletal muscle from sheep, and to measure the effect of changes in animal nutrition on the capacity of the IGF receptors.
Materials and Methods
Tissue was obtained from animals in each of two experiments that investigated the effects and the interaction of GH and nutrition treatments on the GH-IGF axis and growth in sheep. The animals were ranked according to body weight and were randomly allocated to treatment groups. They were housed indoors, penned individually and, unless fasted, received a pelleted diet formulated for sheep. The pellets contained lucerne 60%. barley 30%. linseed oil 5%. and molasses 5 % (NRM Feeds; Auckland, New Zealand). Water was available at all times.
Recombinant bovine somatotropin (GH) was supplied by Dr. A. Mudd of American Cyanamid (Princeton, NJ). Purified natural ovine IGF-1 and IGF2 were supplied by Dr. L. Moore of Wallaceville Animal Research Center (Wallaceville, New Zealand). Both preparations were homogeneous on reversed-phase HPLC with less than 0.01% cross-contamination (Moore et al., 1989) . Recombinant human IGF-1 was supplied by Dr. B. D. Burleigh of International Minerals and Chemical Corporation (Terre Haute, IN). This preparation contained two conformations of the hormone, only one ofwhich binds significantly to ovine IGF binding proteins (Hodgkinson et al., 1989a) . Before use. the preparation was resolved into the two conformations by reversed-phase HPLC and the material with limited binding capacity was discarded (Hodgkinson et al., l989b) . Purified natural bovine insulin (I 1882) was purchased from Sigma (St Louis, MO). Recombinant human IGF1, extracted ovine IGF-1, and extracted ovine IGF2 were radiolabeled and purified using the iodogen method (Salacinski et al., 1981) as previously reported (Hodgkinson et al., 1989a) . Experiment 1 used skeletal muscle from 8-month-old wether lambs (n = 19). The animals were allocated to four groups and underwent 6 weeks of treatment. The treatment groups were high nutrition (3% of body weightlday in pellets; n = 4), low nutrition (1.25% of body weightlday in pellets; n = 5). high nutrition and GH (0.25 mglkglday; n = 5 ) , and low nutrition and GH (n = 5 ) . For Experiment 2, skeletal muscle was collected from 6-month-old ewe lambs that had been fed (n = 2) ad libitum on pellets or fasted (n = 2) for 5 days.
Small pieces of muscle were removed from the hind limb at slaughter and snap-frozen in liquid niuogen. Cryosections were cut and thaw-mounted in pairs on microscope slides, then returned to the freezer and incubated within a week of being cut. Binding of ['2sI]-IGF-1 was measured in Experiment 1 and binding of ['2'I]-IGF1 and ['*'I]-IGF-2 was measured in Experiment 2. One section of each pair on the slide was incubated with ['2'I]-IGF (1.4 nglml) alone to determine total binding. The other was incubated with [12'I]-IGF and unlabeled homologous IGF (1 &ml) together to determine nonspecific binding, or together with the unlabeled heterologous IGF (1 pg/ml) or unlabeled insulin (10 pglml or 10 nglml). Binding that remained after incubation with any unlabeled heterologous hormone was termed residual binding. Specific binding, as presented in Results, was the difference between total binding and nonspecific binding or residual binding. Three pairs of sections from each animal were incubated for each combination of [ '2'I]-IGF and unlabeled hormone.
A detailed description of the incubation protocol has been published elsewhere (Elliott et al., 1992) . Briefly, sections were pre-incubated in 0.17 M Tris-HCI buffer for 10 min, followed by a 2-hr incubation in 0.17 M Tris-HCI buffer containing 1% BSA, 5 mM MgC12, 1 mM phenylmethylsulfonyl fluoride, radiolabeled hormone (20,000 cpmlsection), and unlabeled hormone when appropriate. The sections were then washed in 0.17 M Tris-HCI buffer with 0.25% BSA and 0.01% Triton X-100 before being fixed in Bouin's fluid (Stefanini et al., 1967) and air-dried. The slides were then placed against X-Omat AR5 film (Kodak; Rochester, NY) for 3 days and the developed film was used to estimate the exposure period for sections while under NTB-2 emulsion (Kodak). For [12'I]-IGF1 incubations this was determined to be 7 weeks for Experiment 1 and 4 weeks for Experiment 2. Autoradiographs from [ I2'I]-IGF-2 incubations in Experiment 2 were exposed under emulsion for 1 week. After application of the emulsion, the sections were exposed at 4°C and the resulting autoradiographs were developed according to the manufacturer's instructions. Finally, the autoradiographs were stained with Ehrlich's hematoxylin and alcoholic eosin.
Radiographic grains were counted by use of a microscope and a computerassisted video system. Purpose-developed software enabled grains to be counted within a frame marked on the monitor screen that corresponded to a standard area of section (400 pm2). Selection of the sites on autoradiographs for counting was achieved with the use of random numbers and the X Q coordinates on the microscope stage. For each animal 9-12 sections showed total binding (['2'I]-IGF alone), three sections showed nonspecific binding ([ '2'I]-IGF and the homologous unlabeled IGF), and six to nine sections showed residual binding ([ 12'I]-IGF and the heterologous unlabeled IGF-or 10 pglml unlabeled insulin or 10 nglml unlabeled insulin).
Six sites per tissue type (muscle fiber, connective tissue, nerves) were counted for each section, and the data for each tissue from individual animals were averaged before statistical analysis by ANOVA. Sites of connective tissue were defined as regions of epimysium, perimysium, and endomysium, including collagen, elastic fibers, and fibroblasts, and containing blood vessels (Junqueira and Carneiro, 1980) .
Results
Results are presented as column graphs of specific binding for each radiolabeled hormone and tissue type (Figures 1-3 ). This was calculated by the difference in grain counts between total binding and nonspecific binding or residual binding for each incubation.
Bars on the columns are pooled standard errors of difference which indicate whether or not the specific binding is significantly different from zero. When specific binding was not demonstrated with competitive inhibition of [ 'Z'I]-IGF binding by the homologous unlabeled hormone, data are not presented for characterization of the binding using heterologous hormones.
Experiment 1
For the 8-month-old lambs that received variable nutrition and GH treatments, specific binding of [ '2'I]-IGF-1 was demonstrated in connective tissue (Figures 1 and 4; pGO.001) but not muscle fiber (Figure 1) or nerves (grand mean of radiographic grains per unit area; total binding 16, nonspecific binding 18, pooled SED 5.0; n = 14). There was no difference in the amount of ['Z51]-IGF1 binding to connective tissue between the treatment groups. Unlabeled insulin at a concentration of 10 pg/ml, but not at 10 ng/ml, successfully competed for [ 'zsI]-IGF-l binding sites (pGO.OOl), suggesting that the binding site was the Type 1 receptor and not the insulin receptor. This experiment showed that binding sites for [ '251]-IGF1 in skeletal muscle of young growing lambs were limited in distribution to connective tissue and were insensitive to changes in the nutritional and GH status of the animals.
Experiment 2
O n the basis of results from Experiment 1 which suggested that the Type 1 receptor in connective tissue was insensitive to changes in nutrition, Experiment 2 was undertaken to verify whether this was so, the severity of nutritional stress being increased by fasting of the animals. The binding of both ['251]-IGF-1 and [ 'z51]-IGF-2 was measured. Specific binding of ['251]-IGF-1 ( Figure 2 ) was demonstrated in both the connective tissue (pGO.01, pd0.05) and muscle fiber (pd0.05). Binding was greater in the connective tissue of fasted than of fed animals (pd0.05) but was similar in the muscle fiber of both groups. In muscle fiber and connective tissue, the binding sites showed characteristics of the Type 1 receptor. Lower specific binding in connective tissue of the fed animals resulted in the grain counts for unlabeled IGF-2 and the high concentration of insulin approaching statistical significance at the 5% level (kale = 3.9 and 4.2, respectively; tcrit = 4.3), but both hormones were effective as competitors for [1Z51]-IGF-1 binding in the con- nective tissue of the fasted group and the muscle fiber of both groups (pG0.05). CO-incubation of [ 'Z51]-IGF1 with the low concentration of insulin failed to demonstrate specific binding. Specific binding of ['251 ]-IGF2 was demonstrated in the connective tissue (pdO.01) but not the muscle fiber of both groups (Figure 3) . The binding to connective tissue did not vary with animal treatment. None of the unlabeled heterologous hormones was an effective competitor for binding. Failure of the high concentration of insulin to compete for [ '251]-IGF2 binding suggests that the binding site was the Type 2 receptor or an IGF binding protein with substantially greater affinity for IGF2 than for IGF-1. Qualitative observations of specific binding of [ '251]-IGF-1 and [ '251]-IGF-2 were made as the autoradiographs were being analyzed. The greatest densities of radiographic grains after incubations with both radiolabeled IGFs were associated with blood vessels. Binding of ['z'I]-IGF-2 appeared greater to venules than to nearby arterioles ( Figure 5 also appeared to be more localized to fibroblast nuclei than binding of [ 1251]-IGF-l ( Figure 6 ).
Discussion
The autoradiographic analysis of radiolabeled IGF binding, using light microscopy, has revealed information that could not be established using binding assays with membrane receptor preparations. The first is the location of binding sites within skeletal muscle. Experiment 1 established that binding sites with characteristics of the Type 1 IGF receptor were located solely in the connective tissue of 8-month-old lambs. Because connective tissue often constitutes only a small percentage of the mass of skeletal muscle, the presence of these receptors may not have been detected in the biochemical studies of membrane preparations (Lowe et al., 1989) . The subsequent finding in Experiment 2 that Type 1 receptors were present in both connective tissue and muscle fibre at six months old, suggests that an ontogenic change in the expression of Type 1 receptors may have taken place. Alexandrides et al. (1989) measured the developmental expression of binding sites for IGF1, IGF2, and insulin to skeletal muscle membranes from rats and concluded that the induction of specific binding for each hormone was distinct in terms of the ontogenic timing, binding capacity, and pattern of expression. Our data also suggest that ovine Type 1 receptors for individual tissue components of skeletal muscle are differentially regulated during postnatal growth. The possibility remains that the observed changes in ['2'I]-IGF-l binding to muscle fiber may be influenced by another experimental variable. The 8-monthold lambs were castrated males and the 6-month-old lambs were female. Patterns of receptor induction for IGF-1 may be regulated in some manner by the sex hormones.
The presence of binding sites for [ 1Z51]-IGF-2 in connective tissue is supported by the report of [ 12'I]-IGF-2 binding to cultured fibroblasts (Thorsson et al., 1985) and immunohistochemical localization of the Type 2 receptor to muscle fiber sheaths and ... perimysium in rats (Valentino et al., 1988) . No receptors for [ lz51]-IGF-2 were identified on muscle fiber in Experiment 2, despite reports of Type 2 receptors having been identified on cultured myoblasts (Dodson et al., 1987) . A comparison of the binding of [ 1251]-IGF-1 and [ '251]-IGF-2 to connective tissue receptors shows a number of features suggesting that the binding site differed for each IGF. IGF-2 was a more effective competitor for [ 12SI]-IGF-l binding than the reverse, and the [ 1251]-IGF-2 binding appeared localized to the cell nuclei to a greater extent than [ '2sI]-IGF-1 binding. The fact that [ 12>I]-IGF-2 bound solely to connective tissue whereas [ '251]-IGF-1 bound to both connective tissue and muscle fiber in Experiment 2 indicates that cross-binding of the radiolabeled hormone to the heterologous IGF receptor did not occur, and verifies the presence of a heterogeneous population of IGF receptors in skeletal muscle. In addition, the presence of Type 1 receptors but not Type 2 receptors in muscle fiber at 6 months of age suggests that the ontogenic development of Type 1 and Type 2 receptors may differ in the same tissue, as was also concluded by Alexandrides et al. (1989) .
There was no evidence of binding sites for ['251]-IGF1 in nerves throughout the muscle sections. Binding sites for [ 1251]-IGF-1 have been reported in other neural tissues (Lesniak et al., 1988; Ocrant et al., 1988; Smith et al., 1988) . and IGF immunoreactivity has been reported in peripheral nerves Uennische et al. 1987; Andersson et al., 1986) . making the lack of binding sites detected in the current experiment somewhat surprising.
The finding that there was no change in IGF-1 binding to connective tissue in Experiment 1 suggests that Type 1 receptors in connective tissue are insensitive to nutritional and hormonal manipu-lation of the animal. A direct effect of GH on IGF-1 mRNA in skeletal muscle has been demonstrated by others (Isgaard et al., 1989) , and when IGFl is administered to sheep it is cleared to peripheral tissues and lymph (Hodgkinson et al., 1991) , indicating that the availability of GH and IGF-1 to muscle is unlikely to be limited. By use of IGF binding systems in vitro, down-regulation of Type 1 receptors by prior exposure to IGF-1 and GH has been reported (Freemark et al., 1990; Rosenfeld and Dollar, 1982) , but this does not appear to have been a mechanism utilized in vivo in our experiment. These reports suggest that the Type 1 receptor in connective tissue is not sensitive to regulation by GH, IGF-1, and moderate changes in nutrition.
In contrast, the data for specific binding of [ 1251]-IGF1 to connective tissue in Experiment 2 suggests that extreme change in nutrition does regulate the binding of [ '251]-IGF-1 to connective tissue. Increased [ '251]-IGF-1 binding with fasting has been reported for several rat tissues, and the changes have been determined to be due to alteration of number and affinity of Type 1 receptors (Lowe et al., 1989) . These authors suggest that tissue responsiveness to fasting may depend on whether preservation of a particular function is required. In cultured myoblasts, Type 1 receptors are downregulated in number by exposure to IGFl and IGF2 (Dodson et al., 1987) . If the same principle applies in vivo, a reduced number of Type 1 receptors in well-fed animals might be expected.
A simpler interpretation of a difference in receptors between fed and fasted animals is that it may arise from reduced occupancy of a comparable number of binding sites. This has been considered for the binding of placental lactogen by Freemark et al. (1990) .
These authors found that the specific binding in liver preparations from ewes was greater with fasting, whether or not the membranes were treated with magnesium chloride to remove endogenously bound hormone. In addition, Lowe et al. (1989) reported an increase in the mRNA of the Type 1 receptor in some fasted tissues, also suggesting a positive response by cells to increase the number of receptors.
The [ 12'I]-IGF-2 binding to connective tissue was not altered by fasting, suggesting that control of Type 2 receptors is relatively insensitive to extreme malnutrition and its associated hormonal changes. The binding of [ 12'I]-IGF-2 to cultured cells is not altered by pre-treatment with IGF-1 or IGF-2 (de Vroede et al., 1984) , and pre-treatment of cells with GH does not alter binding of IGF-2 (Thorsson et al., 1985) . The stability of populations of Type 2 receptors is also indicated by steady-state internalization and recycling (Oka and Czech, 1986) , highly reproducible specific binding (Thorsson et al., 1985) , and binding that is independent of incubation temperature in cultured cell systems (Blanchard et al., 1988) .
In conclusion, the binding data for ['251]-IGF1 and [ 1251]-IGF2 to skeletal muscle of growing lambs have revealed that the receptors for each IGF are distinct in their distribution, capacity, and ontogenic development. Our data collectively suggest that the GH-IGF axis is involved with the physiological adaptation of lambs to fasting. The functions of connective tissue as a support organ for muscle fiber may well be regulated to some degree by Type 1 receptors, and this question requires attention. Binding sites for IGF-2 in connective tissue were abundant but did not alter with fasting, so any function of the Type 2 receptor in mediating changes associated with altered nutrition remains undetermined.
